Paricalcitol in the treatment of MHD with secondary hyperparathyroidism and bone pain

Int Urol Nephrol. 2023 May;55(5):1385-1388. doi: 10.1007/s11255-022-03421-z. Epub 2022 Nov 29.

Jingyi Chen^{1

2}, Liang Cai^{3

4

5}, Xiangqiong Wen^{1

2}, Xin Xie^{1

2}, Santao Ou^{6

7}

¹ Department of Nephrology, The Affiliated Hospital of Southwest Medical University, The 25th Taiping Street, Luzhou, 646000, Sichuan Province, China.
² Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan Province, China.
³ Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
⁴ Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China.
⁵ Academician (Expert) Workstation of Sichuan Province, Luzhou, Sichuan, China.
⁶ Department of Nephrology, The Affiliated Hospital of Southwest Medical University, The 25th Taiping Street, Luzhou, 646000, Sichuan Province, China. ousantao@163.com.
⁷ Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan Province, China. ousantao@163.com.

No abstract available

Publication types